Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health
WARREN, N.J.–(BUSINESS WIRE)–
Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer, effective April 27, 2026. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon’s evolution into a more agile, consumer-centric organization.
Manso will lead Haleon’s integrated US marketing organization, advancing how the company connects with consumers in the moments where health decisions actually happen. He will work across categories and global teams to integrate data, technology and human insight, strengthening Haleon’s ability to deliver more personalized, transparent and relevant health experiences.
His appointment comes at a time of significant transformation in consumer health, as individuals take a more active, self-directed role in managing their well-being and increasingly expect seamless, personalized, and on-demand experiences. In this environment, marketing is emerging as a critical driver of trust – shaping how companies show up across every touchpoint in everyday life.
At Haleon, Manso will focus on strengthening modern marketing capabilities across the US business—driving growth within and across categories, and advancing priority areas including Medicare Advantage OTC, GLP-1, and emerging platforms such as Women’s and Pediatric Health. His role will also support Haleon’s broader ambition to build a more connected, insight-led marketing ecosystem that reflects how consumers engage with health today.
“Consumers are taking a more active role in managing their health—and that’s raising expectations for the brands they trust,” saidNathalie Gerschtein, US CEO and President, North America, Haleon.“At Haleon, we see an opportunity to rethink how we engage—making it more personal, transparent, and connected to the moments where health decisions happen. Richard brings a forward-looking perspective at the intersection of marketing, data and technology that will help us continue to evolve and deliver better everyday health with humanity.”
Manso brings experience across marketing, technology and digital transformation, most recently serving in senior leadership roles at Google, where he led large-scale B2B marketing programs and helped drive adoption of data and AI-enabled marketing solutions. His background also includes leadership roles spanning consumer brands and digital strategy.
Richard Manso commented: “I’m excited to join Haleon at such a pivotal moment for both the company and the consumer health category. As people take greater ownership of their health, there’s a real opportunity to rethink how brands show up, not just as products, but as trusted partners in everyday life. I’m looking forward to working with Nathalie and the team to bring together data, technology, and creativity to build more meaningful connections with consumers and drive the next phase of growth.”
Manso will report directly to Nathalie and serve as a member of the US Leadership Team.
About Haleon
Haleon (LSE/NYSE: HLN) is a globally leading consumer company that is solely focused on better everyday health. Haleon’s product portfolio spans three major categories – Oral Health, Over-the-Counter (OTC), and Wellness. Its long-standing brands – such as Advil, Centrum, Parodontax, Sensodyne, Theraflu, and TUMS – are built on trusted science, innovation and deep human understanding. For more information on Haleon and its brands, please visit www.haleon.com or contact [email protected].
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427877997/en/
KEYWORDS: New Jersey United States North America
INDUSTRY KEYWORDS: Retail Health Other Retail General Health Pharmaceutical Biotechnology
MEDIA:
| Logo |
 |